Daiichi Medical Research

Daiichi Medical Research, Inc. (DMR) was a U.S.-based pharmaceutical research and development company and a subsidiary of the Japanese firm Daiichi Pharmaceutical Co., Ltd. Established in 2004 and headquartered in Edison, New Jersey, the company was created to streamline the clinical development and regulatory evaluation of drug candidates for the United States market. Its research activities primarily supported the parent company's pipeline in cardiovascular disease, oncology, and infectious diseases, including key products such as Benicar (olmesartan) and the co-development of prasugrel. In April 2006, following the global merger of Daiichi Pharmaceutical and Sankyo Company, Daiichi Medical Research was integrated with other U.S. subsidiaries to form Daiichi Sankyo, Inc. The company was recognized for its early implementation of advanced clinical data management systems to enhance R&D productivity.